Taichung, Taiwan

Chung-Y Hsu



Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Innovations of Chung-Y Hsu in Stem Cell Research

Introduction

Chung-Y Hsu is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of stem cell research, particularly in enhancing the expression of insulin-like growth factor 1 receptor in mesenchymal stem cells. With a total of seven patents to his name, Hsu's work is paving the way for advancements in regenerative medicine.

Latest Patents

Chung-Y Hsu's latest patents include innovative methods for enhancing the expression of insulin-like growth factor 1 receptor in umbilical cord mesenchymal stem cells. One of his notable patents describes a method that involves culturing umbilical cord mesenchymal stem cells in a medium containing platelet-derived growth factor BB (PDGF-BB) to boost the expression of this crucial receptor. Another patent focuses on a similar approach for mesenchymal stem cells, which also utilizes PDGF-BB to enhance receptor expression. These methods have the potential to significantly impact treatments for various conditions, including brain tissue damage.

Career Highlights

Chung-Y Hsu is affiliated with China Medical University, where he continues to conduct research and develop innovative solutions in the field of stem cell therapy. His work has garnered attention for its potential applications in regenerative medicine and tissue repair.

Collaborations

Hsu collaborates with esteemed colleagues such as Woei-Cherng Shyu and Chen-Huan Lin. Their combined expertise contributes to the advancement of research in stem cell applications and therapies.

Conclusion

Chung-Y Hsu's contributions to stem cell research through his innovative patents are noteworthy. His work not only enhances our understanding of mesenchymal stem cells but also opens new avenues for therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…